Multiple Myeloma Treatment Landscape from 2011-2017: Results from the Population-Based "Identifying Outcomes in Real-World Multiple Myeloma"
The treatment landscape of multiple myeloma (MM) is rapidly evolving with the availability of new therapeutic options leading to improved responses and survival rates. The INFORMM study, an ongoing, province-wide study in Alberta, Canada (population of 4.3 million in 2018), is examining treatment patterns in a real-world setting using population-based administrative data to better understand management of newly diagnosed multiple myeloma (NDMM) and outcomes in this era of novel therapies.
Year of Publication: 2019
Authors: Eileen Shaw, FF Liu, Guanmin Chen, Jason Tay, Megan Farris, Tara Cowling, Victor Jimenez-Zepeda
Journal Title: HemaSphere